Get started
Author

Panagiotis Katsaounis

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study
2024 · Luis G. Paz-Ares, Oscar Juan-Vidal, et al. · Journal of Clinical Oncology · 167
PDF
Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group
2017 · F Koinis, S Agelaki, et al. · British Journal of Cancer · 42
PDF
Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
2016 · D. Mavroudis, A. Matikas, et al. · Annals of Oncology · 37
A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy
2016 · A Kotsakis, A Matikas, et al. · British Journal of Cancer · 28
PDF
Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
2015 · P. Katsaounis, A. Kotsakis, et al. · Cancer Chemotherapy and Pharmacology · 22
Gastrointestinal Stromal Tumors (GIST): A Prospective Analysis and an Update on Biomarkers and Current Treatment Concepts
2015 · Anna Koumarianou, Panagiota Economopoulou, et al. · Biomarkers in Cancer · 20
PDF
Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges
2011 · A.K. Koutras, I. Starakis, et al. · Current Medicinal Chemistry · 20
Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study
2023 · Filippos Koinis, Zafeiris Zafeiriou, et al. · Cancers · 13
PDF
MINOAS: A Single-arm Translational Phase II Trial of FOLFIRI Plus Aflibercept as First-line Therapy in Unresectable, Metastatic Colorectal Cancer
2019 · Alexios Matikas, John Souglakos, et al. · Targeted Oncology · 13
Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group
2017 · Panagiotis Katsaounis · Annals of Gastroenterology · 12
Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG)
2016 · on behalf of the HORG’s Lung Cancer Working Group, A. Matikas, et al. · Cancer Chemotherapy and Pharmacology · 11
An extranodal NK/T cell lymphoma, nasal type, with specific immunophenotypic and genotypic features
2008 · Panagiotis Katsaounis, Alexandra Alexopoulou, et al. · International Journal of Hematology · 10
A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: The ‘LUNGFUL’ Study
2021 · Giannis Mountzios, Anna Koumarianou, et al. · Cancers · 9
PDF
Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
2013 · Nikolaos Charalambakis, Vassilis Kouloulias, et al. · Frontiers in Oncology · 9
PDF
Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG)
2016 · N. Kentepozidis, P. Economopoulou, et al. · Clinical & Translational Oncology · 7
Small cell carcinoma of the stomach: A report of two cases and a review of the literature
2018 · Marios Bakogeorgos, Dimitrios Kalkanis, et al. · Molecular and Clinical Oncology · 6
PDF
Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG)
2015 · A. Kotsakis, N. Kentepozidis, et al. · Lung Cancer · 6
Genetic alterations in HRAS gene in relation to outcome and response to cetuximab in head and neck squamous cell carcinoma.
2012 · Theodoros Rampias, Athina Giagini, et al. · Journal of Clinical Oncology · 6
Bone disease in patients with cirrhosis of different etiology and severity; are Klotho protein and osteoprotegerin potential biomarkers?
2022 · Panagiotis V. Katsaounis, Emilia S. Hadjiyannis, et al. · Scandinavian Journal of Gastroenterology · 5
H-RAS and PIK3CA mutations and response to cetuximab in head and neck squamous cell carcinoma (HNSCC).
2011 · T. Rampias, A. Giagini, et al. · Journal of Clinical Oncology · 5
A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer
2022 · G. Carlsson, A. Koumarianou, et al. · ESMO Open · 3
Antibiotic exposure and risk of breast cancer: A causal association or a skyfall?
2013 · Anna Koumarianou, Efrosyni D Manali, et al. · Journal of Clinical Oncology · 3
Adjuvant taxane-based chemotherapy treatment in older patients with early breast cancer: A pooled analysis of five phase III trials from the Hellenic Oncology Research Group
2025 · Oraianthi Fiste, Lambros Vamvakas, et al. · Journal of Geriatric Oncology · 2
Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group
2022 · Stefania Kokkali, Emmanouil Saloustros, et al. · Current Oncology · 2
PDF
Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece
2025 · EVANGELOS BOURNAKIS, IOANNIS XANTHAKIS, et al. · Anticancer Research · 1
PDF
Works count: 33
Citation count: 460
H-index: 11
I10-index: 12
Year
Topic
Type